News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Synthes, Inc. (SYST) Chairman Emeritus Hansjörg Wyss Joins Osiris Therapeutics, Inc. (OSIR) As A Strategic Advisor


5/2/2014 9:55:06 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading stem cell company focused on developing and marketing products in wound care, orthopedic and sports medicine markets, announced today that Hansjörg Wyss will serve as a strategic advisor to the company. Mr. Wyss was the founder and a major shareholder of Synthes and served as its Chairman until the company was sold to Johnson & Johnson in 2012 for $19.7 billion.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES